MENU
+Compare
DXR
Stock ticker: NASDAQ
AS OF
Aug 11, 04:25 PM (EDT)
Price
$10.09
Change
+$0.07 (+0.70%)
Capitalization
49.72M

DXR Daxor Corp Forecast, Technical & Fundamental Analysis

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement... Show more

DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DXR with price predictions
Aug 08, 2025

DXR sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for DXR moved above the 200-day moving average on July 07, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for DXR just turned positive on August 07, 2025. Looking at past instances where DXR's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DXR advanced for three days, in of 203 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 189 cases where DXR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where DXR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DXR as a result. In of 119 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

DXR broke above its upper Bollinger Band on July 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DXR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.389) is normal, around the industry mean (10.661). P/E Ratio (6.638) is within average values for comparable stocks, (62.050). DXR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.847). DXR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (23.202) is also within normal values, averaging (83.916).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DXR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
DXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

DXR paid dividends on January 12, 2018

Daxor Corp DXR Stock Dividends
А dividend of $0.03 per share was paid with a record date of January 12, 2018, and an ex-dividend date of January 05, 2018. Read more...
A.I. Advisor
published General Information

General Information

a provider of original medical equipment for medical personnel

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
109 Meco Lane
Phone
+1 212 330-8500
Employees
12
Web
https://www.daxor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARBFF24.92N/A
N/A
ARB Corp., Ltd.
NODB57.25N/A
N/A
North Dallas Bank & Trust Co. (TX)
TBVPY36.94N/A
N/A
Thai Beverage Public Co., Ltd.
MAPPF0.09N/A
N/A
PROSTAR HLDGS INC.
BCEPF13.59N/A
N/A
BCE Inc.

DXR and Stocks

Correlation & Price change

A.I.dvisor tells us that DXR and COO have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DXR and COO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXR
1D Price
Change %
DXR100%
-4.57%
COO - DXR
20%
Poorly correlated
+1.58%
SHC - DXR
20%
Poorly correlated
+24.51%
DCTH - DXR
13%
Poorly correlated
-1.77%
AORT - DXR
10%
Poorly correlated
+25.23%
CERS - DXR
10%
Poorly correlated
-2.42%
More

Groups containing DXR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXR
1D Price
Change %
DXR100%
-4.57%
Pharmaceuticals: Other
industry (105 stocks)
4%
Poorly correlated
+0.07%
Pharmaceuticals
industry (394 stocks)
4%
Poorly correlated
+0.45%